Skip to main content
Equibles

Ying Luo, Ph.D.

CEO

Gyre Therapeutics, Inc. (GYRE)
Gyre Therapeutics, Inc. (GYRE)

Board Member

Gyre Therapeutics, Inc. (GYRE)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Ying Luo, Ph.D.

Ying Luo, Ph.D. is recorded as CEO and Board Member at Gyre Therapeutics, Inc. (GYRE). Gyre Therapeutics, Inc. reported in an 8-K filed March 2, 2026 that Ying Luo, Ph.D. was appointed Class I director. Gyre Therapeutics, Inc. reported in an 8-K filed March 2, 2026 that Ying Luo, Ph.D. was appointed Chief Executive Officer and President of the Company. Gyre Therapeutics, Inc. reported in an 8-K filed December 27, 2022 that Ying Luo, Ph.D. was appointed Director, effective December 26, 2022.

“In accordance with the Merger Agreement, effective immediately after the Effective Time, the Company will appoint Ying Luo, Ph.D. as Chief Executive Officer and President of the Company and to the Board as a Class I director.”
Gyre Therapeutics, Inc. Form 8-K, filed March 2, 2026 · Read the filing
“In accordance with the Merger Agreement, effective immediately after the Effective Time, the Company will appoint Ying Luo, Ph.D. as Chief Executive Officer and President of the Company and to the Board as a Class I director.”
Gyre Therapeutics, Inc. Form 8-K, filed March 2, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Gyre Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.